mihailgrey / iStockphoto.com
2 July 2018Americas
AstraZeneca’s Zomig patents upheld in precedential ruling
The US Court of Appeals for the Federal Circuit has ruled that a passing mention in the prior art of a formulation that references the claimed ingredient and administration may not be enough to invalidate a patent claim.
